FDA Inspection
The Procter & Gamble Manufacturing CompanyThe Procter & Gamble Manufacturing Company – FDA Inspection, Sep 11, 2024
Record Details
This FDA Inspection record concerns The Procter & Gamble Manufacturing Company, with an inspection on September 11, 2024, issued by the Baltimore District Office, covering human drugs.
- Inspection Date
- September 11, 2024
- Product Type
- Human Drugs
View Company Profile
ID · 5af9dfa3-2139-40e6-9b04-c6ce58c9ba6c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1241122
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of The Procter & Gamble Manufacturing Company
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 27, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for The Procter & Gamble Manufacturing Company
- FDA Inspection 982035 - 2016-05-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.